✦ LIBER ✦

Pharmacokinetics of Dexamethasone and Valspodar, a P-glycoprotein (mdr1) Modulator: Implications for Coadministration

✍ Scribed by John M. Kovarik; Harpal S. Purba; Michele Pongowski; Christophe Gerbeau; Henri Humbert; Edgar A. Mueller

Book ID: 112113765
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 599 KB
Volume: 18
Category: Article
ISSN: 0277-0008
DOI: 10.1002/j.1875-9114.1998.tb03142.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coadministration of P-Glycoprotein Modul

Coadministration of P-Glycoprotein Modulators on Loperamide Pharmacokinetics and Brain Distribution

✍ Montesinos, R. N.; Moulari, B.; Gromand, J.; Beduneau, A.; Lamprecht, A.; Pelleq 📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 240 KB

Pharmacokinetics of irinotecan (CPT-11)

Pharmacokinetics of irinotecan (CPT-11) in wildtype-and P-glycoprotein- (P-gp) knockout (mdr1a/1b (−/−)) mice

✍ U. Mayer; B. Mueller; D.K. Hossfeld 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Altered oral bioavailability and pharmac

Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A

✍ Sean X. Peng; David M. Ritchie; Martin Cousineau; Earl Danser; Robert DeWire; Ja 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Effects of coadministration of dietary supplement biochanin A (BA) on the pharmacokinetics of three P-glycoprotein substrates, paclitaxel, digoxin, and fexofenadine, were investigated in rats. With BA coadministration, the oral bioavailability and peak plasma concentration were markedly increased by

Modulation of MDR1 and CYP3A Expression

Modulation of MDR1 and CYP3A Expression by Dexamethasone: Evidence for an Inverse Regulation in Adrenals

✍ E. Sérée; P.H. Villard; A. Hevér; N. Guigal; F. Puyoou; B. Charvet; H. Point-Sco 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 535 KB

MDR1–P-glycoprotein (ABCB1)-Mediated Dis

MDR1–P-glycoprotein (ABCB1)-Mediated Disposition of Amyloid-β Peptides: Implications for the Pathogenesis and Therapy of Alzheimer’s Disease

✍ Jedlitschky, G; Vogelgesang, S; Kroemer, H K 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Individual and combined roles of CYP3A,

Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel

✍ Robert A.B. van Waterschoot; Jurjen S. Lagas; Els Wagenaar; Hilde Rosing; Jos H. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 181 KB

## Abstract Docetaxel is one of the most widely used anticancer drugs. A major problem with docetaxel treatment, however, is the considerable interpatient variability in docetaxel exposure. Another disadvantage of the drug is that it has a very low oral bioavailability and can, therefore, only be a